July 9, 2018
US rejects entry to 5 antibiotic-laced shrimp imports in June
Through the first half of this year, the US Food and Drug Administration (FDA) rejected a total of 25 entry lines of shrimp for reasons related to veterinary drug residues, the Southern Shrimp Alliance reported.
The five shrimp entry line refusals in June were from exporters in India and China.
Dongguan Ateier Import and Export Co. Ltd. of China had three entry lines refused for shrimp contaminated with veterinary drug residues on June 7.